Tirou, K.; Maida, M. J.; Maleque, S.; Biju, M.; Evans, J.; Aldridge, A.; Geen, J.; Hawkes, N. D.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA75
Academic Journal
This article presents a study to establish the prevalence of aspirin, NSAID and COX2 inhibitor use in general medical patients admitted to secondary care. It also assess rates of adverse gastrointestinal events for each group. The study concludes that aspirin is a more common cause of upper gastrointestinal (GI) bleed and anaemia in general medical patients than NSAID or COX2 inhibitors. Patients taking aspirin tend to be elderly with a greater degree of comorbidity. GI prophylaxis in patients taking low dose aspirin may be warranted if two or more background risk factors are present.


Related Articles

  • Low-dose aspirin increases risk of major haemorrhages.  // Reactions Weekly;10/14/2006, Issue 1123, p1 

    The article reports that the use of low-dose aspirin increases the risk of haemorrhages. Aspirin use was associated with an increased risk of any major haemorrhage, and a significantly increased risk of major GI haemorrhage and intracranial haemorrhage, compared with placebo, the risk of fatal...

  • Gastrointestinal hemorrhage and use of NSAIDS.  // American Family Physician;7/1/1994, Vol. 50 Issue 1, p201 

    Evaluates the use of prescription and over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with ulcers or non-ulcer-related upper gastrointestinal (GI) hemorrhage. Peptic ulcer disease as a cause of GI bleeding; NSAID use differences between patients with gastric ulcers...

  • The Risk of Acute Major Upper Gastrointestinal Bleeding Among Users of Aspirin and Ibuprofen at Various Levels of Alcohol Consumption. Kaufman, David W.; Kelly, Judith Parsells; Wiholm, Bengt-Erik; Laszlo, András; Sheehan, Jane E.; Koff, Raymond S.; Shapiro, Samuel // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3189 

    OBJECTIVE: Major upper gastrointestinal bleeding (UGIB) is the most important adverse effect of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Alcoholic beverages also precipitate UGIB. This analysis was conducted to evaluate whether the deleterious effects of NSAIDs are...

  • Use of Physician Education and Computer Alert to Improve Targeted Use of Gastroprotection Among NSAID Users. Coté, Gregory A.; Rice, John P.; Bulsiewicz, William; Norvell, John P.; Christensen, Keri; Bobb, Anne; Postelnick, Michael; Howden, Colin W. // American Journal of Gastroenterology;May2008, Vol. 103 Issue 5, p1097 

    BACKGROUND: Gastrointestinal (GI) hemorrhage accounts for 200–400,000 admissions in the United States annually. Around 50% of patients with bleeding ulcer have used aspirin and/or nonsteroidal anti-inflammatory drugs (NSAIDs). Misoprostol and proton pump inhibitors (PPIs) may reduce...

  • Značaj Helicobacter pylori infekcije i nesteroidnih antiinflamatornih lekova kod bolesnika sa krvarenjem iz gornjeg dela gastrointestinalnog trakta. Golubović, Gradimir; Tomašević, Ratko; Radojević, Biljana; Pavlović, Aleksandar; Dugalić, Predrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul2007, Vol. 64 Issue 7, p445 

    Background/Aim. Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drugs (NSAIDs) use are considered to be the most important risk factors having influence on the onset of bleeding gastroduodenal lesions. Whether there is an interaction between H. pylori infection and...

  • Risk of Upper Gastrointestinal Bleeding Associated With Use of Low-Dose Aspirin. Sørensen, Henrik Toft; Mellemkjær, Lene; Blot, William J.; Nielsen, Gunnar Lauge; Steffensen, Flemming Hald; McLaughlin, Joseph K.; Olsen, Jørgen H. // American Journal of Gastroenterology;Sep2000, Vol. 95 Issue 9, p2218 

    OBJECTIVE: Aspirin products are known to cause irritation and injury to the gastric mucosa. We examined the risk of hospitalization for upper gastrointestinal bleeding with use of low-dose aspirin. METHODS: This was a cohort study based on record linkage between a population-based prescription...

  • Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-induced Damage by Rabeprazole. Robinson, Malcolm // Internal Medicine Alert;4/29/2008, Vol. 30 Issue 8, p57 

    The article discusses the effectiveness of rabeprazole in reducing gastroduodenal damages caused by aspirin and other nonsteroidal anti-inflammatory agents (NSAIDs). The study shows that aspirin can cause gastric and duodenal submucosal hemorrhages and erosion but can be prevented by...

  • NSAIDs and Alcohol: Never the Twain Shall Mix? Pfau, Patrick R.; Lichtenstein, Gary R. // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3098 

    Offers a look at the interaction of alcohol and aspirin or nonsteroidal anti-inflammatory drugs (NSAID) in upper gastrointestinal bleeding (UGIB). Pathophysiology of NSAID and aspirin-induced ulceration and mucosal injury; Effect of alcohol on the risk of UGIB among NSAID users; Reference to a...

  • Pharmacogenomics of acetylsalicylic acid and other nonsteroidal anti-inflammatory agents: clinical implications. Yiannakopoulou, Eugenia // European Journal of Clinical Pharmacology;Jul2013, Vol. 69 Issue 7, p1369 

    Purpose: Pharmacogenomics investigates interindividual genetic variability in the DNA sequence of drug targets, drug-metabolizing enzymes or disease genes, RNA expression, or protein translation of genes affecting drug response and drug safety. Aspirin and other nonsteroidal anti-inflammatory...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics